EMA is launching a pilot programme to support the translation of basic research developments into medicines in the European Economic Area (EEA).The pilot is open to academic and non-profit ATMP developers.
During the pilot, EMA will provide enhanced regulatory support for up to five selected ATMPs. EMA will guide the participants through the regulatory process with the aim to optimise the development of the ATMPs, starting from best practice principles for manufacturing to planning clinical development that meets regulatory standards.
Learn more about this pilot programme by following the link below:
